-
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Rating of "Buy" from Analysts
Source: Buzz FX / 06 Nov 2024 05:31:16 America/New_York
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Average Rating of "Buy" from Analysts Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Shares of SpringWorks Therapeutics, Inc.
Read more...